Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramesh Poluru

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Plos One|July 8, 2021
Lessons from implementation research on community management of Possible Serious Bacterial Infection (PSBI) in young infants (0-59 days), when the referral is not feasible in Palwal district of Haryana, IndiaRupak Mukhopadhyay, Narendra Kumar Arora, Pradeep Kumar Sharma, et al.
Indian Pediatrics|February 13, 2019
Pediatric Appropriate Evaluation Protocol for India (PAEP-India): Tool for Assessing Appropriateness of Pediatric HospitalizationManoja Kumar Das, Narendra Kumar Arora, Ramesh Poluru, et al.
Trials|July 5, 2024
Role of central endpoint adjudication and challenges in trials on neonatal sepsis-a case of ProSPoNS trialAnju Pradhan Sinha, Dilip Raja, Kamlesh S Mahajan, et al.
Pediatrics|October 14, 2025
Transparent Reporting of Pediatric Clinical Trial Interventions: TIDieR-Children and AdolescentsKatherine Goren, Veronica Ka Wai Lai, Ami Baba, et al.
Trials|April 2, 2021
Evaluating the efficacy of a multistrain probiotic supplementation for prevention of neonatal sepsis in 0-2-month-old low birth weight infants in India-the "ProSPoNS" Study protocol for a phase III, multicentric, randomized, double-blind, placebo-controlled trialAnju Pradhan Sinha, Subodh S Gupta, Ramesh Poluru, et al.
The Lancet. Child & Adolescent Health|June 12, 2026
CONSORT-Children and Adolescents (CONSORT-C) 2026 extension statement: enhancing the reporting and impact of paediatric randomised trialsAmi Baba, Maureen Smith, Beth K Potter, et al.
BMJ (Clinical Research Ed.)|February 24, 2026
CONSORT-Children and Adolescents (CONSORT-C) 2026 extension statement: enhancing the reporting and impact of paediatric randomised trialsAmi Baba, Maureen Smith, Beth K Potter, et al.
The Lancet. Child & Adolescent Health|June 12, 2026
SPIRIT-Children and Adolescents (SPIRIT-C) 2026 extension statement: enhancing the reporting and usefulness of paediatric randomised trial protocolsAmi Baba, Maureen Smith, Beth K Potter, et al.
BMJ (Clinical Research Ed.)|February 24, 2026
SPIRIT-C 2026 explanation and elaboration: recommendations for enhancing the reporting and usefulness of paediatric randomised trial protocolsAmi Baba, Maureen Smith, Beth K Potter, et al.
JAMA Pediatrics|February 24, 2026
SPIRIT-Children and Adolescents (SPIRIT-C) 2026 Extension Statement: Enhancing the Reporting and Usefulness of Pediatric Randomized Trial ProtocolsAmi Baba, Maureen Smith, Beth K Potter, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Plos One|July 8, 2021
Lessons from implementation research on community management of Possible Serious Bacterial Infection (PSBI) in young infants (0-59 days), when the referral is not feasible in Palwal district of Haryana, IndiaRupak Mukhopadhyay, Narendra Kumar Arora, Pradeep Kumar Sharma, et al.
Indian Pediatrics|February 13, 2019
Pediatric Appropriate Evaluation Protocol for India (PAEP-India): Tool for Assessing Appropriateness of Pediatric HospitalizationManoja Kumar Das, Narendra Kumar Arora, Ramesh Poluru, et al.
Trials|July 5, 2024
Role of central endpoint adjudication and challenges in trials on neonatal sepsis-a case of ProSPoNS trialAnju Pradhan Sinha, Dilip Raja, Kamlesh S Mahajan, et al.
Pediatrics|October 14, 2025
Transparent Reporting of Pediatric Clinical Trial Interventions: TIDieR-Children and AdolescentsKatherine Goren, Veronica Ka Wai Lai, Ami Baba, et al.
Trials|April 2, 2021
Evaluating the efficacy of a multistrain probiotic supplementation for prevention of neonatal sepsis in 0-2-month-old low birth weight infants in India-the "ProSPoNS" Study protocol for a phase III, multicentric, randomized, double-blind, placebo-controlled trialAnju Pradhan Sinha, Subodh S Gupta, Ramesh Poluru, et al.
The Lancet. Child & Adolescent Health|June 12, 2026
CONSORT-Children and Adolescents (CONSORT-C) 2026 extension statement: enhancing the reporting and impact of paediatric randomised trialsAmi Baba, Maureen Smith, Beth K Potter, et al.
BMJ (Clinical Research Ed.)|February 24, 2026
CONSORT-Children and Adolescents (CONSORT-C) 2026 extension statement: enhancing the reporting and impact of paediatric randomised trialsAmi Baba, Maureen Smith, Beth K Potter, et al.
The Lancet. Child & Adolescent Health|June 12, 2026
SPIRIT-Children and Adolescents (SPIRIT-C) 2026 extension statement: enhancing the reporting and usefulness of paediatric randomised trial protocolsAmi Baba, Maureen Smith, Beth K Potter, et al.
BMJ (Clinical Research Ed.)|February 24, 2026
SPIRIT-C 2026 explanation and elaboration: recommendations for enhancing the reporting and usefulness of paediatric randomised trial protocolsAmi Baba, Maureen Smith, Beth K Potter, et al.
JAMA Pediatrics|February 24, 2026
SPIRIT-Children and Adolescents (SPIRIT-C) 2026 Extension Statement: Enhancing the Reporting and Usefulness of Pediatric Randomized Trial ProtocolsAmi Baba, Maureen Smith, Beth K Potter, et al.
Pageof 3